SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-005338
Filing Date
2022-02-23
Accepted
2022-02-23 13:05:12
Documents
2
Period of Report
2022-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 10432
2 EXPLANATION OF RESPONSES i50790891.htm EX-99.1 4458
  Complete submission text file 0001567619-22-005338.txt   17327
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Reporting) CIK: 0001080014 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38670 | Film No.: 22662241
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Issuer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1209 ORANGE STREET WILMINGTON DE 19801
Business Address 1209 ORANGE STREET WILMINGTON DE 19801 877 202 1097
Innoviva Strategic Opportunities LLC (Reporting) CIK: 0001842875 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38670 | Film No.: 22662240